Gilbert Omenn is professor of internal medicine, human genetics, and public health and director of the Center for Computational Medicine & Bioinformatics at the University of Michigan. He served as executive vice president for medical affairs and as chief executive officer of the University of Michigan Health System from 1997 to 2002. He was dean of the School of Public Health, and professor of medicine and environmental health, University of Washington, Seattle, 1982 to 1997. His research interests include cancer proteomics, chemoprevention of cancers, public health genetics, science-based risk analysis, and health policy. He is a director of Amgen Inc. and Armune Biosciences Inc. He leads the Human Proteome Project for the international Human Proteome Organization. He was president of the American Association for the Advancement of Science (AAAS) in 2006. He was elected an ambassador of the Paul G. Rogers Society for Global Health Research; served on the advisory board for the Shanghai Jiao Tong University Medical School; and is on the boards of CRDF-Global, The Hastings Center for Bioethics, CNA and the Center for Public Integrity, and previously Salzburg Global Seminar. Professor Omenn is the author of 534 research papers and scientific reviews and author/editor of 18 books. He is a member of the Institute of Medicine of the National Academy of Sciences, the American Academy of Arts and Sciences, the Association of American Physicians, and the American College of Physicians. He chaired the presidential/congressional Commission on Risk Assessment and Risk Management ("Omenn Commission"), served on the National Commission on the Environment, and chaired the NAS/NAE/IOM Committee on Science, Engineering and Public Policy. He received the John W. Gardner Legacy of Leadership Award from the White House Fellows Association in 2004 and the Walsh McDermott Medal from the Institute of Medicine in 2008 for long-term contributions to the IOM and the National Academy of Sciences. In 2012 he was appointed to the Scientific Management Review Board of the NIH. He is active in cultural and educational organizations. Professor Omenn received a B.A. summa cum laude from Princeton, M.D. magna cum laude from Harvard Medical School, and Ph.D. in genetics from the University of Washington.